Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study - Ageno, W; Mantovani, L G; Haas, S (Lancet Haematol, 2016)
, et al.